It is the butterfly effect in action. Weak growth outlooks in the Gulf states are prompting greater competition from local clinics, stemming the flow of visitors to the world’s top medical tourism destination.
That is clouding the outlook for Thailand’s healthcare shares, which surged more than 800 percent over the past seven years, as valuations start to look stretched amid falling demand. Bangkok’s Bumrungrad Hospital PLC, known as the grandaddy of international clinics, has slumped 16 percent since early March after patient volumes from the United Arab Emirates (UAE), its second-biggest source of overseas visitors, fell 20 percent in the first quarter.
Thailand attracted as many as 1.8 million international patients last year, many staying on afterward for a beach holiday. More than one in three foreigners treated at Bumrungrad are from the Gulf states, and Kasikorn Securities Co says declining growth in the region and a rise in competition from clinics in the UAE, where the government is encouraging its citizens to undergo medical care at home, are curbing demand.
“In the short term, the economic slowdown in the the Middle East will weaken some investors’ confidence on earnings growth for domestic hospital operators,” said Jintana Mekintharanggur, the Bangkok-based director of equity investment at Manulife Asset Management.
“We are still bullish on the sector” in the long term, as it will benefit from growth in nations such as Myanmar and Vietnam that have less-developed health systems, she said.
The SET Health Care Services Index has fallen 2.7 percent since closing at a record high on April 21. It is still the best-performing industry group in the SET Index, rallying almost 28 percent over the past 12 months. It trades at 6.8 times its book value, compared with 3.8 for the MSCI World Health Care Index.
The health gauge fell 0.3 percent as of 10:31am in Bangkok yesterday, the worst performer among 28 industry groups on the SET Index, which was up 0.7 percent. Bangkok Dusit Medical Services PLC, which has the biggest weighting on the measure, dropped 0.8 percent.
“Most hospital stocks have very stretched valuations, which has probably spurred some concern about overestimated earnings potential,” said Adithep Vanabriksha, Bangkok-based chief investment officer at Aberdeen Asset Management PLC. “We still see their growth potential, but have to be very careful with the current share prices.”
Between 1.3 million and 1.8 million medical tourists traveled to Thailand last year, according to figures from Patients Beyond Borders, a consulting firm in Chapel Hill, North Carolina. The nation is well known for cosmetic and sex change procedures. Medical tourism generated 107 billion baht (US$3 billion) of revenue in 2014, according to the latest Thai government estimate.
Sitting at the apex of the industry is Bumrungrad, which attracts more than half a million foreign patients a year and has a network of 32 referral offices everywhere from Mongolia to Ethiopia. Sixty-seven percent of revenue came from overseas visitors last quarter, company figures showed. Burmese were the biggest source, accounting for 8.4 percent of total patients, followed by 8.3 percent from the UAE and 5.9 percent from Oman.
Kasikorn Securities downgraded its earning forecasts for Bumrungrad by 8 percent to 13 percent in 2016 to 2018 to reflect the weak economic outlook in the Gulf and rising competition from Abu Dhabi’s al-Noor Hospitals Group, according to a May 19 note by analyst Jitima Ratanatam in Bangkok.
The UAE’s economy has been hit by the plunge in oil prices since the middle of 2014 and is forecast to expand 2.5 percent this year, from more than 7 percent in 2012.
Other Thai hospitals are also under pressure. Chiang Mai Ram Medical Business PLC reported a 41 percent slump in first-quarter profit. Bangkok Dusit was downgraded to “neutral” from “outperform” by Credit Suisse Group AG last week.
Recognizing the importance of healthcare to the economy, Thai Prime Minister Prayuth Chan-ocha’s military government has drafted a 10-year plan to promote the sector. As part of the plan, the staying period for medical treatment for patients from China, Laos, Cambodia, Myanmar and Vietnam has been tripled to 90 days.
Even if Middle East demand keeps declining, growth in Southeast Asia is likely to support the industry, said Voravan Tarapoom, Bangkok-based chief executive officer at BBL Asset Management Co.
Manulife has cut holdings in Bangkok Dusit because its rising share price provided an opportunity to lock in profit, Jintana said.
It is buying Bumrungrad because it has dropped to an attractive level and Manulife is also looking at other health companies, but is wary of high valuations, she said.
“Healthcare stocks were the good defensive stocks during the market downturn,” said Kasem Prunratanamala, the head of research at CIMB Securities Co in Bangkok. “Now, with the high valuations, those shares have lost a little bit of allure.”
The US dollar was trading at NT$29.7 at 10am today on the Taipei Foreign Exchange, as the New Taiwan dollar gained NT$1.364 from the previous close last week. The NT dollar continued to rise today, after surging 3.07 percent on Friday. After opening at NT$30.91, the NT dollar gained more than NT$1 in just 15 minutes, briefly passing the NT$30 mark. Before the US Department of the Treasury's semi-annual currency report came out, expectations that the NT dollar would keep rising were already building. The NT dollar on Friday closed at NT$31.064, up by NT$0.953 — a 3.07 percent single-day gain. Today,
‘SHORT TERM’: The local currency would likely remain strong in the near term, driven by anticipated US trade pressure, capital inflows and expectations of a US Fed rate cut The US dollar is expected to fall below NT$30 in the near term, as traders anticipate increased pressure from Washington for Taiwan to allow the New Taiwan dollar to appreciate, Cathay United Bank (國泰世華銀行) chief economist Lin Chi-chao (林啟超) said. Following a sharp drop in the greenback against the NT dollar on Friday, Lin told the Central News Agency that the local currency is likely to remain strong in the short term, driven in part by market psychology surrounding anticipated US policy pressure. On Friday, the US dollar fell NT$0.953, or 3.07 percent, closing at NT$31.064 — its lowest level since Jan.
The New Taiwan dollar and Taiwanese stocks surged on signs that trade tensions between the world’s top two economies might start easing and as US tech earnings boosted the outlook of the nation’s semiconductor exports. The NT dollar strengthened as much as 3.8 percent versus the US dollar to 30.815, the biggest intraday gain since January 2011, closing at NT$31.064. The benchmark TAIEX jumped 2.73 percent to outperform the region’s equity gauges. Outlook for global trade improved after China said it is assessing possible trade talks with the US, providing a boost for the nation’s currency and shares. As the NT dollar
The Financial Supervisory Commission (FSC) yesterday met with some of the nation’s largest insurance companies as a skyrocketing New Taiwan dollar piles pressure on their hundreds of billions of dollars in US bond investments. The commission has asked some life insurance firms, among the biggest Asian holders of US debt, to discuss how the rapidly strengthening NT dollar has impacted their operations, people familiar with the matter said. The meeting took place as the NT dollar jumped as much as 5 percent yesterday, its biggest intraday gain in more than three decades. The local currency surged as exporters rushed to
RSS